These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36731641)

  • 1. Delivery of small molecule mast cell activators for West Nile Virus vaccination using acetalated dextran microparticles.
    Hendy DA; Johnson-Weaver BT; Batty CJ; Bachelder EM; Abraham SN; Staats HF; Ainslie KM
    Int J Pharm; 2023 Mar; 634():122658. PubMed ID: 36731641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.
    Johnson-Weaver BT; Choi HW; Yang H; Granek JA; Chan C; Abraham SN; Staats HF
    Front Immunol; 2021; 12():730346. PubMed ID: 34566991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses.
    Chen N; Johnson MM; Collier MA; Gallovic MD; Bachelder EM; Ainslie KM
    J Control Release; 2018 Mar; 273():147-159. PubMed ID: 29407676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection.
    Johnson MM; Collier MA; Hoang KV; Pino EN; Graham-Gurysh EG; Gallovic MD; Zahid MSH; Chen N; Schlesinger L; Gunn JS; Bachelder EM; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):5336-5348. PubMed ID: 30296381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.
    Collier MA; Junkins RD; Gallovic MD; Johnson BM; Johnson MM; Macintyre AN; Sempowski GD; Bachelder EM; Ting JP; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):4933-4946. PubMed ID: 30281314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy.
    Chen N; Gallovic MD; Tiet P; Ting JP; Ainslie KM; Bachelder EM
    J Control Release; 2018 Nov; 289():114-124. PubMed ID: 30261204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight.
    Chen N; Collier MA; Gallovic MD; Collins GC; Sanchez CC; Fernandes EQ; Bachelder EM; Ainslie KM
    Int J Pharm; 2016 Oct; 512(1):147-157. PubMed ID: 27543351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicits protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    mSphere; 2024 Jul; 9(7):e0016024. PubMed ID: 38920382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-COBRA hemagglutinin formulated with cGAMP microparticles elicit protective immune responses against influenza viruses.
    Zhang X; Shi H; Hendy DA; Bachelder EM; Ainslie KM; Ross TM
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merozoite surface protein 2 adsorbed onto acetalated dextran microparticles for malaria vaccination.
    Stiepel RT; Batty CJ; MacRaild CA; Norton RS; Bachelder E; Ainslie KM
    Int J Pharm; 2021 Jan; 593():120168. PubMed ID: 33309558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine.
    Pena ES; Batty CJ; Hendy DA; Yang S; Ontiveros-Padilla L; Stiepel RT; Ting JP; Ainslie KM; Bachelder EM
    Int J Pharm; 2024 Mar; 652():123836. PubMed ID: 38266940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.
    Junkins RD; Gallovic MD; Johnson BM; Collier MA; Watkins-Schulz R; Cheng N; David CN; McGee CE; Sempowski GD; Shterev I; McKinnon K; Bachelder EM; Ainslie KM; Ting JP
    J Control Release; 2018 Jan; 270():1-13. PubMed ID: 29170142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product.
    Kauffman KJ; Do C; Sharma S; Gallovic MD; Bachelder EM; Ainslie KM
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4149-55. PubMed ID: 22833690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.
    Hoang KV; Curry H; Collier MA; Borteh H; Bachelder EM; Schlesinger LS; Gunn JS; Ainslie KM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2052-62. PubMed ID: 26787696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral Response to the Acetalated Dextran M2e Vaccine is Enhanced by Antigen Surface Conjugation.
    Batty CJ; Pena ES; Amouzougan EA; Moore KM; Ainslie KM; Bachelder EM
    Bioconjug Chem; 2023 Aug; 34(8):1447-1458. PubMed ID: 37458383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinyl Sulfone-functionalized Acetalated Dextran Microparticles as a Subunit Broadly Acting Influenza Vaccine.
    Batty CJ; Lifshits LM; Hendy DA; Eckshtain-Levi M; Ontiveros-Padilla LA; Carlock MA; Ross TM; Bachelder EM; Ainslie KM
    AAPS J; 2023 Jan; 25(1):22. PubMed ID: 36720729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.
    Gallovic MD; Schully KL; Bell MG; Elberson MA; Palmer JR; Darko CA; Bachelder EM; Wyslouzil BE; Keane-Myers AM; Ainslie KM
    Adv Healthc Mater; 2016 Oct; 5(20):2617-2627. PubMed ID: 27594343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.
    Hoang KV; Borteh HM; Rajaram MV; Peine KJ; Curry H; Collier MA; Homsy ML; Bachelder EM; Gunn JS; Schlesinger LS; Ainslie KM
    Int J Pharm; 2014 Dec; 477(1-2):334-43. PubMed ID: 25447826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
    Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A
    Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.
    Peine KJ; Bachelder EM; Vangundy Z; Papenfuss T; Brackman DJ; Gallovic MD; Schully K; Pesce J; Keane-Myers A; Ainslie KM
    Mol Pharm; 2013 Aug; 10(8):2849-57. PubMed ID: 23768126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.